Domo, Inc. Class B Common Stock

Go to Domo, Inc. Class B Common Stock Website

$7.45

(%)
Live
Previous Close

$7.45

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$284.4 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company off...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance. Marvell said fourth-quarter revenue increased 1% year-over-year to $1.427 billion, which beat the consensus estimate of $1.42 billion. The chip designer reported quarterly earnings of 46 cents per share, which was in line with analyst estimates. Marvell sees first-quarter revenue of $1.15 billion, plus or minus 5%, versus estimates of $1.371 billion. The company sees first-quarter adjusted earnings of 23 cents per share, plus or minus 5 cents per share, versus estimates of 40 cents per share. The company authorized a $3 billion buyback. Marvell Technology shares dipped 9.6% to $76.91 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Ainos, Inc. (NASDAQ: AIMD) jumped 140% to $2.6899 after dipping 18% on Thursday. Psyence Biomedical Ltd. (NASDAQ: PBM) shares climbed 139% to $3.0350. Psyence Biomedical recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study. Safe and Green Development Corporation (NASDAQ: SGD) shares jumped 138% to $1.57 after the company announced financing for the Norman Berry Expansion in Atlanta, Georgia. MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) shares climbed 48.5% to $1.36. MIRA Pharmaceuticals, last month, announced a research collaboration with Pharmaseed to research and evaluate Ketamir for patients with major depressive disorder and post-traumatic stress disorder. CERo Therapeutics Holdings, Inc. (NASDAQ: CERO) shares climbed 35.4% to $4.17 after surging over 20% on Thursday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients. Willdan Group, Inc. (NASDAQ: WLDN) gained 30.4% to $25.89 after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance above estimates. Also, the company secured a contract worth approximately $30 million to $50 million over three years. The Joint Corp. (NASDAQ: JYNT) gained 29% to $11.80 following fourth-quarter results. Smith & Wesson Brands, Inc. (NASDAQ: SWBI) jumped 25.8% to $16.91 after the company reported better-than-expected third-quarter financial results. Research Frontiers Incorporated ...

Related tickers: MIRA, PBR, SWBI, AIRE, GRFS, ASLE, DDI, SGD, PRCH, NXU, IOT, EGOX, HCI, VIRX, PBM, MOBX, DKL, AEVA, COST, CERO, JYNT, CTOS, CRMT, ADAP, AIMD, GIFI, DOMO, GROM, MRVL, MAX, COOK, PRTS, NXL, RWAY, RDNT, IMRN, PIK, REFR, RDFN, BBAI, WLDN, AMLX, SWVL, SMR, CCL, MDB, BREA, GCO, DOGZ, CRML, IEP, AQST.

Read Full Article

DOMO earnings call for the period ending December 31, 2023.

Related tickers: DOMO.

Read Full Article
Trending Tickers
LASE

XNAS

$2.04
(%)
PACW

XNAS

$7.54
(%)
SMFL

XNAS

$3.58
(%)
SQ

XNYS

$69.47
(%)
MLGO

XNAS

$0.00
(%)